John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, FL, USA.
Neurology. 2013 Mar 12;80(11):982-9. doi: 10.1212/WNL.0b013e31828727d4. Epub 2013 Feb 13.
Recently, vacuolar protein sorting 35 (VPS35) and eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) have been identified as 2 causal Parkinson disease (PD) genes. We used whole exome sequencing for rapid, parallel analysis of variations in these 2 genes.
We performed whole exome sequencing in 213 patients with PD and 272 control individuals. Those rare variants (RVs) with <5% frequency in the exome variant server database and our own control data were considered for analysis. We performed joint gene-based tests for association using RVASSOC and SKAT (Sequence Kernel Association Test) as well as single-variant test statistics.
We identified 3 novel VPS35 variations that changed the coded amino acid (nonsynonymous) in 3 cases. Two variations were in multiplex families and neither segregated with PD. In EIF4G1, we identified 11 (9 nonsynonymous and 2 small indels) RVs including the reported pathogenic mutation p.R1205H, which segregated in all affected members of a large family, but also in 1 unaffected 86-year-old family member. Two additional RVs were found in isolated patients only. Whereas initial association studies suggested an association (p = 0.04) with all RVs in EIF4G1, subsequent testing in a second dataset for the driving variant (p.F1461) suggested no association between RVs in the gene and PD.
We confirm that the specific EIF4G1 variation p.R1205H seems to be a strong PD risk factor, but is nonpenetrant in at least one 86-year-old. A few other select RVs in both genes could not be ruled out as causal. However, there was no evidence for an overall contribution of genetic variability in VPS35 or EIF4G1 to PD development in our dataset.
最近,液泡分选蛋白 35(VPS35)和真核翻译起始因子 4 伽马 1(EIF4G1)已被确定为 2 个导致帕金森病(PD)的基因。我们使用全外显子组测序快速平行分析这 2 个基因的变异。
我们对 213 名 PD 患者和 272 名对照个体进行了全外显子组测序。那些在 Exome Variant Server 数据库和我们自己的对照数据中频率小于 5%的罕见变异(RVs)被认为是分析对象。我们使用 RVASSOC 和 SKAT(序列核关联测试)进行联合基因关联测试,并使用单变异测试统计量进行分析。
我们发现了 3 种新的 VPS35 变异,它们改变了 3 例患者的编码氨基酸(非同义)。2 种变异存在于多灶性家族中,均与 PD 无关。在 EIF4G1 中,我们发现了 11 种(9 种非同义突变和 2 种小插入缺失)RVs,包括报道的致病性突变 p.R1205H,它在一个大家族的所有受影响成员中都存在,而在一个 86 岁的未受影响的家族成员中也存在。另外 2 种 RVs仅在孤立患者中发现。尽管最初的关联研究表明 EIF4G1 中的所有 RVs 都与 PD 相关(p=0.04),但随后在第二个数据集对驱动变异(p.F1461)进行的测试表明,基因中的 RVs 与 PD 之间没有关联。
我们证实特定的 EIF4G1 变异 p.R1205H 似乎是一个很强的 PD 风险因素,但至少在一位 86 岁的患者中并不具有穿透性。这两个基因中的其他一些选择性 RVs 也不能排除为因果关系。然而,在我们的数据集没有证据表明 VPS35 或 EIF4G1 中的遗传变异总体上对 PD 的发展有贡献。